Lipoprotein (a). Heterogeneity and biological relevance.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

96 citing papers in PubMed.

1. Changes in lipoprotein(a), oxidized phospholipids, and LDL subclasses with a low-fat high-carbohydrate diet.Journal of lipid research · 2010
   Trial
2. Issues concerning the monitoring of statin therapy in hypercholesterolemic subjects with high plasma lipoprotein(a) levels.Lipids · 2002
   Trial
3. Gemfibrozil and Mediterranean diet for patients with high plasma levels of lipoprotein [Lp(a)] and cholesterol--pilot study.Cardiovascular drugs and therapy · 1995
   Trial
4. Hormonal regulation of serum Lp (a) levels. Opposite effects after estrogen treatment and orchidectomy in males with prostatic carcinoma.The Journal of clinical investigation · 1992
   Trial
5. Effects of treatment with verapamil SR and captopril on the lipid profile of hypertensive patients.Drugs · 1992
   Trial
6. Lipoprotein (a) as a risk factor for prosthetic heart valve thrombosis.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2025
   Article
7. Dyslipidaemia and inflammation are risks for subclinical atherosclerotic vascular disease among chronic kidney failure patients in South Africa.PloS one · 2025
   Article
8. The indicative effects of apolipoproteins on organic erectile dysfunction: bridging Mendelian randomization and case-control study.Frontiers in endocrinology · 2024
   Article
9. N-Acetylcysteine and Atherosclerosis: Promises and Challenges.Antioxidants (Basel, Switzerland) · 2023
   Review
10. Crosstalk between neurological, cardiovascular, and lifestyle disorders: insulin and lipoproteins in the lead role.Pharmacological reports : PR · 2022
    Review
11. Osteonecrosis of the Jaws in Patients with Hereditary Thrombophilia/Hypofibrinolysis-From Pathophysiology to Therapeutic Implications.International journal of molecular sciences · 2022
    Review
12. The Evaluation of Serum Lipids Profile in Patients with Pemphigus Vulgaris: A Case-Control Study.The Malaysian journal of medical sciences : MJMS · 2020
    Article
13. Reduction of cardiovascular risk in subjects with high lipoprotein (a) levels.Journal of thoracic disease · 2017
    Article
14. Effect of diet-induced weight loss on lipoprotein(a) levels in obese individuals with and without type 2 diabetes.Diabetologia · 2017
    Article
15. Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology.Journal of lipid research · 2016
    Review
16. The application of multiple reaction monitoring and multi-analyte profiling to HDL proteins.Lipids in health and disease · 2014
    Article
17. Review of lipid and lipoprotein(a) abnormalities in childhood arterial ischemic stroke.International journal of stroke : official journal of the International Stroke Society · 2014
    Review
18. Inhibition of neointima formation through DNA vaccination for apolipoprotein(a): a new therapeutic strategy for lipoprotein(a).Scientific reports · 2013
    Article
19. Multifaceted role of tocotrienols in cardioprotection supports their structure: function relation.Genes & nutrition · 2012
    Article
20. A Systematic Literature Review of the Association of Lipoprotein(a) and Autoimmune Diseases and Atherosclerosis.International journal of rheumatology · 2012
    Article

36 more citing papers are in PubMed but not listed here.

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as